Nakho Chang

Title: Nakho Chang: Innovator in Cancer Treatment

Introduction

Nakho Chang is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.

Latest Patents

Nakho Chang holds a patent for "Anti-TIGIT antibodies and uses thereof." This patent discloses a novel antibody that specifically binds to the tumor-immunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain). The patent includes a nucleic acid encoding the antibody, a vector, and a host cell containing the nucleic acid. It also outlines a method for producing the antibody and a pharmaceutical composition that contains the antibody as an active ingredient. The antibody and its pharmaceutical composition are particularly useful for the treatment of cancer or tumors. He has 1 patent to his name.

Career Highlights

Nakho Chang is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work focuses on developing innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.

Collaborations

Nakho Chang has collaborated with notable colleagues, including Kwang-Hoon Lee and June Hyung Lee. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Nakho Chang's innovative work in developing anti-TIGIT antibodies represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in the pursuit of medical breakthroughs.